Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
Label-Free Biosensors Show Early Promise
Optical and Nonoptical Platforms Are On the Heels of Conventional ELISA
- For the last three decades the predominant means of detecting and measuring antigen-antibody interactions, for research or clinical purposes, has been the ELISA method. While simple, cheap, and relatively specific and sensitive, its hegemony is now threatened by a variety of innovative technologies. ELISA technology is well-known and widely ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.